The world's second vaccine against malaria was launched on Monday as the Ivory Coast began a routine vaccine program using shots developed by the University of Oxford and the Serum Institute of India.

LONDON, July 15 (Reuters) - The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine programme using shots developed by the University of Oxford and ...

Children in Ivory Coast received the first doses of a new, relatively cheap malaria vaccine on Monday, a step that has been hailed as a key moment in the battle against one of the world’s most ...

Ivory Coast administered the first doses of the world’s second malaria vaccine this week, according to the vaccine’s manufacturers, marking the latest development in a decades-long effort to ...

Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the ...

The WHO in December 2023 added the R21/Matrix-M malaria vaccine to its list of prequalified vaccines. Children in Ivory Coast received the first dose of the new malaria vaccine on Monday.

A total of 656,600 doses of the new R21/Matrix-M malaria vaccine have been delivered to the Ivory Coast, where clinicians will initially vaccinate 250,000 children aged from newborn to 23 months ...

LONDON — The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine program using shots developed by the University of Oxford and the Serum ...

Children in Ivory Coast received the first doses of a new, relatively cheap malaria vaccine on Monday, a step that has been hailed as a key moment in the battle against one of the world’s most ...

A second malaria vaccine has been introduced, this time in the West African nation of Côte d'Ivoire. According to a report, the nation started a routine vaccination campaign with vaccines created ...

The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine programme using shots developed by the University of Oxford and the Serum Institute of India.